FDA
-
-
-
-
-
-
-
Mizuho Starts Pulse Biosciences (PLSE) at Outperform
-
-
-
-
-
-
-
Pulse Biosciences Announces First Enrollment in the NANOCLAMP AF Study
-
-
-
-
-
-
-
Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2024 Financial Results
-
-
-
-
-
-
-
Pulse Biosciences Reports Business Updates and Third Quarter 2024 Financial Results
-
-
-
-
-
-
-
Pulse Biosciences Reports Business Updates and First Quarter 2024 Financial Results
-
-
-
-
-
-
-
Pulse Biosciences Announces First-in-Human Procedures with its Novel CellFX™ Nanosecond Pulsed Field Ablation (nsPFA™) Cardiac Catheter
-
-
-
-
-
-
-
Pulse Biosciences Reports Fourth Quarter & Full Year 2022 Financial Results
-
327,133 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

